---
figid: PMC2518073__JCI0834739.f8
figtitle: Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent
  feedback loop in human cancer
organisms:
- NA
pmcid: PMC2518073
filename: JCI0834739.f8.jpg
figlink: /pmc/articles/PMC2518073/figure/F8/
number: F8
caption: Briefly, mTORC1 activation leads to PI3K and MAPK inhibition through a negative
  feedback loop stemming from S6K1 (left panel), while treatment with mTORC1 inhibitors
  results in a hyperactive RTK/IRS-1/PI3K pathway, increasing the signal toward the
  Ras-Raf1-MEK1/2-ERK pathway (middle panel). Therefore, the combination of MEK and
  mTORC1 inhibitors may provide a therapeutic benefit in the treatment of certain
  cancers through the abrogation of the feedback described in this study (right panel).
  Activated proteins are represented with blue circles and inhibition status with
  red squares.
papertitle: Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent
  feedback loop in human cancer.
reftext: Arkaitz Carracedo, et al. J Clin Invest. 2008 Sep 2;118(9):3065-3074.
year: '2008'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8984913
figid_alias: PMC2518073__F8
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC2518073__F8
ndex: 36af6c11-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2518073__JCI0834739.f8.html
  '@type': Dataset
  description: Briefly, mTORC1 activation leads to PI3K and MAPK inhibition through
    a negative feedback loop stemming from S6K1 (left panel), while treatment with
    mTORC1 inhibitors results in a hyperactive RTK/IRS-1/PI3K pathway, increasing
    the signal toward the Ras-Raf1-MEK1/2-ERK pathway (middle panel). Therefore, the
    combination of MEK and mTORC1 inhibitors may provide a therapeutic benefit in
    the treatment of certain cancers through the abrogation of the feedback described
    in this study (right panel). Activated proteins are represented with blue circles
    and inhibition status with red squares.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - ras
  - Ras64B
  - Akt
  - Pdk1
  - rst
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - aop
  - Raf
  - gig
  - Tsc1
  - Dsor1
  - Rheb
  - Erk7
  - rl
  - Crtc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Mtk
  - S6k
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - SLC22A12
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IRS1
  - RAF1
  - RNASE3
  - TSC2
  - TSC1
  - CCL26
  - MAP2K1
  - MAP2K2
  - RHEB
  - RHEBP1
  - FKBP8
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - RPTOR
  - MAP2K7
  - RPS6KB1
  - Rapamycin
  - Cancer
---
